{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:36:37Z","timestamp":1791218197847,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jinf.2012.10.017","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T15:17:03Z","timestamp":1351091823000},"page":"346-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment"],"prefix":"10.1016","volume":"66","author":[{"given":"Filippo","family":"Bartalesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Spinicci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Attala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mencarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Li Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Mantella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Prignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pimpinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.10.017_bib1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor \u03b1 monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2012.10.017_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: structure, function, and tuberculosis risks","volume":"8","author":"Wallis","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2012.10.017_bib4","first-page":"413","article-title":"Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy","volume":"24","author":"Valesini","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jinf.2012.10.017_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to TNF antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"issue":"RR-5","key":"10.1016\/j.jinf.2012.10.017_bib6","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection \u2013 United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jinf.2012.10.017_bib7","series-title":"Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control","author":"National Institute for Health and Clinical Excellence","year":"2012"},{"key":"10.1016\/j.jinf.2012.10.017_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB gold and TST are both useful for latent TB screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2012.10.017_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2012.10.017_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10096-008-0670-8","article-title":"Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis","volume":"28","author":"Chee","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2012.10.017_bib12","doi-asserted-by":"crossref","first-page":"e5187","DOI":"10.1371\/journal.pone.0005187","article-title":"In\u00a0vivo and in\u00a0vitro effects of anti-tuberculosis treatment on mycobacterial interferon-gamma T-cell response","volume":"4","author":"Sauzullo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2012.10.017_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2334-6-66","article-title":"Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases","volume":"6","author":"Aiken","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2012.10.017_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T-cell based assay for monitoring efficacy of anti-tuberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.10.017_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-9-182","article-title":"New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response","volume":"9","author":"Butera","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2012.10.017_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-11-135","article-title":"IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy","volume":"11","author":"Kabeer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2012.10.017_bib17","unstructured":"Goletti D, Parracino MP, Butera O, Bizzoni F, Casetti R, Dainotto D, et\u00a0al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res."},{"key":"10.1016\/j.jinf.2012.10.017_bib18","unstructured":"Herrmann JL, Belloy M, Porcher R, Simonney N, Aboutaam R, Lebourgeois M, et\u00a0al. Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS One."},{"key":"10.1016\/j.jinf.2012.10.017_bib19","unstructured":"Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Dheda K, et\u00a0al. Persistently elevated T-cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol."},{"key":"10.1016\/j.jinf.2012.10.017_bib20","unstructured":"Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med."},{"key":"10.1016\/j.jinf.2012.10.017_bib21","unstructured":"Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med."},{"key":"10.1016\/j.jinf.2012.10.017_bib22","unstructured":"Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, Pasvol G, et\u00a0al. Effect of treatment of latent tuberculosis infection on the T-cell response to Mycobacterium tuberculosis antigens. J Infect Dis."},{"key":"10.1016\/j.jinf.2012.10.017_bib23","unstructured":"Higuchi K, Harada N, Mori T. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology."},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.rmed.2009.10.006","article-title":"Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak","volume":"104","author":"Lee","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2012.10.017_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB gold in-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2012.10.017_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","article-title":"Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNF\u03b1 inhibitors: the utility of IFN\u03b3 assay","volume":"71","author":"Chen","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2012.10.017_bib27","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/annrheumdis-2011-201036","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011","volume":"71","author":"Furst","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.jinf.2012.10.017_bib28","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","article-title":"Clinical practice. Latent tuberculosis infection","volume":"347","author":"Jasmer","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib29","first-page":"312","article-title":"Comparative study of RT23 and Merieux tuberculin tested among healthy volunteers","volume":"13","author":"Sgountzos","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4 Pt 2","key":"10.1016\/j.jinf.2012.10.017_bib30","first-page":"S221","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jinf.2012.10.017_bib31","first-page":"84","article-title":"T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India","volume":"13","author":"Pai","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2012.10.017_bib32","first-page":"725","article-title":"Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10","volume":"79","author":"Harada","year":"2004","journal-title":"Kekkaku"},{"issue":"11","key":"10.1016\/j.jinf.2012.10.017_bib33","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.jinf.2012.10.017_bib34","first-page":"1286","article-title":"Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts","volume":"12","author":"Franken","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"10.1016\/j.jinf.2012.10.017_bib35","doi-asserted-by":"crossref","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review","volume":"4","author":"van Zyl-Smit","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/CVI.00398-07","article-title":"Reproducibility of QuantiFERON-TB gold in-tube assay","volume":"15","author":"Perry","year":"2008","journal-title":"J Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2012.10.017_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2334-8-11","article-title":"Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study","volume":"28","author":"Goletti","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00045509","article-title":"Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection","volume":"35","author":"Leidl","year":"2010","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.jinf.2012.10.017_bib39","doi-asserted-by":"crossref","first-page":"e12577","DOI":"10.1371\/journal.pone.0012577","article-title":"Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?","volume":"5","author":"Goletti","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jinf.2012.10.017_bib40","doi-asserted-by":"crossref","first-page":"e18315","DOI":"10.1371\/journal.pone.0018315","article-title":"Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders","volume":"6","author":"Delogu","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2012.10.017_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"Goletti","year":"2010","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.jinf.2012.10.017_bib42","doi-asserted-by":"crossref","first-page":"e27539","DOI":"10.1371\/journal.pone.0027539","article-title":"Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood","volume":"6","author":"Chiacchio","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2012.10.017_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinf.2012.03.017","article-title":"IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country","volume":"65","author":"Vanini","year":"2012","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2012.10.017_bib44","doi-asserted-by":"crossref","first-page":"88S","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:46Z","timestamp":1759007866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0163445312003039"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.10.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}